Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.067 AUD | -1.47% |
|
-16.25% | -5.63% |
May. 28 | Noxopharm Joins Alliance for mRNA Medicines; Shares Up Nearly 7% | MT |
Apr. 04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-5.63% | 13.41M | |
+21.85% | 46.93B | |
+37.63% | 39.08B | |
-8.05% | 38.48B | |
+29.04% | 31.01B | |
-13.75% | 26.14B | |
+10.65% | 25.88B | |
+38.43% | 12.53B | |
-6.92% | 11.36B | |
-12.29% | 10.65B |
- Stock Market
- Equities
- NOX Stock
- News Noxopharm Limited
- Noxopharm Advances to the Efficacy Portion of its Phase 2 Prostate Cancer Trial